These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12040294)

  • 1. Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase II study.
    Braud AC; Levy E; Feuilhade F; Otmezguine Y; Calitchi E; Kirova Y; Le Bourgeois JP
    Am J Clin Oncol; 2002 Jun; 25(3):303-7. PubMed ID: 12040294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].
    Chen CM; Shen KW; Liu GY; Wu J; Lu JS; Zhuang CJ; Han QX; Liu BL; Shao ZM; Shen ZZ
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):745-7. PubMed ID: 16836921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
    Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
    Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer.
    Esteban E; de Sande G; Puertas J; Fra J; Palacio I; Vieitez JM; Fernández JL; Muñiz I; Modollel A; Carrasco J; Sala M; Lacave AJ
    Breast Cancer Res Treat; 2000 Jul; 62(2):127-33. PubMed ID: 11016750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
    Halim A; Wahba H
    Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epirubicin/vinorelbine as first line therapy in metastatic breast cancer.
    Baldini E; Tibaldi C; Chiavacci F; Di Lieto M; Fioretto L; Giallom-bardo A; Taviani R; Ghezzi P; Bolognini A; Conte P
    Breast Cancer Res Treat; 1998 May; 49(2):129-34. PubMed ID: 9696395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).
    Yan PW; Huang XE; Jiang Y; Tang JH; Xu HX; Xu X; Jin X
    Asian Pac J Cancer Prev; 2010; 11(4):1115-8. PubMed ID: 21133634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer.
    Nisticò C; Garufi C; Barni S; Frontini L; Gallà DA; Giannarelli D; Vaccaro A; D'Ottavio AM; Terzoli E
    Ann Oncol; 1999 Aug; 10(8):937-42. PubMed ID: 10509155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer.
    Livi L; Paiar F; Santini R; De Luca Cardillo C; Galardi A; Di Cosmo D; Borghesi S; Agresti B; Nosi F; Gavilli S; Biti GP
    Anticancer Drugs; 2006 Oct; 17(9):1081-5. PubMed ID: 17001182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    J Clin Oncol; 2007 Apr; 25(10):1232-8. PubMed ID: 17296975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
    Medioni J; Huchon C; Le Frere-Belda MA; Hofmann H; Bats AS; Eme D; Andrieu JM; Oudard S; Lecuru F; Levy E
    Drugs R D; 2011; 11(2):147-57. PubMed ID: 21679005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).
    Chua S; Smith IE; A'Hern RP; Coombes GA; Hickish TF; Robinson AC; Laing RW; O'Brien ME; Ebbs SR; Hong A; Wardley A; Mughal T; Verrill M; Dubois D; Bliss JM;
    Ann Oncol; 2005 Sep; 16(9):1435-41. PubMed ID: 15946977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer.
    Garrone O; Principe E; Occelli M; Mercuri M; Numico G; Granetto C; Di Costanzo G; Rattazzi PD; Merlano M
    Anticancer Drugs; 2004 Jan; 15(1):23-7. PubMed ID: 15090739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.
    Nisticò C; De Matteis A; Rossi E; Carnino F; Valenza R; Agostara B; Bria E; Farris A; Cremonesi M; D'Ottavio AM; Vaccaro A; Garufi C; Giunta S; Botti C; Perrone F; Terzoli E
    Anticancer Res; 2005; 25(2B):1343-8. PubMed ID: 15865089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
    Abrial C; Van Praagh I; Delva R; Leduc B; Fleury J; Gamelin E; Sillet-Bach I; Penault-Llorca F; Amat S; Chollet P
    Oncologist; 2005 Apr; 10(4):242-9. PubMed ID: 15821244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer.
    Van Praagh I; Cure H; Leduc B; Charrier S; Le Bouedec G; Achard JL; Ferriere JP; Feillel V; De Latour M; Dauplat J; Chollet P
    Oncologist; 2002; 7(5):418-23. PubMed ID: 12401904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer--a phase II trial.
    Elomaa I; Joensuu H; Blomqvist C
    Acta Oncol; 2003; 42(4):309-14. PubMed ID: 12899502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer].
    Huang O; Chen CM; Wu JY; Hu Z; Hou YF; Zhang JX; Liu GY; Di GH; Lu JS; Wu J; Shao ZM; Shen ZZ; Shen KW
    Zhonghua Wai Ke Za Zhi; 2009 Apr; 47(7):511-5. PubMed ID: 19595208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.
    Kerbrat P; Roché H; Bonneterre J; Veyret C; Lortholary A; Monnier A; Fumoleau P; Fargeot P; Namer M; Chollet P; Goudier MJ; Audhuy B; Simon H; Montcuquet P; Eymard JC; Walter S; Clavère P; Guastalla JP;
    Br J Cancer; 2007 Jun; 96(11):1633-8. PubMed ID: 17505516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.